Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
International Immunopharmacology|March 12, 2026
Lactate drive M2 polarization via OXPHOS and Cebpb and accelerate peripheral nerve regenerationWei Li, Xiao Wang, Xiaoli Liu, et al.International Immunopharmacology|August 18, 2022
Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and painWei Li, Jie Liang, Shaohua Li, et al.International Immunopharmacology|April 1, 2025
INSL3 promotes macrophage polarization to an immunosuppressive phenotype via the cAMP downstream signaling pathway and Akt/mTOR pathwayMengting Zhou, Yi Liu, Cuiping Li, et al.International Journal of Cancer|April 29, 2026
Targeting HIF as a Promising Approach to Synergize With Immune Checkpoint InhibitorsShuai Li, Yi Liu, Xiaoli Liu, et al.International Immunopharmacology|May 29, 2023
The role of CXCL1/CXCR2 axis in neurological diseasesSuli Jiang, Jie Liang, Wei Li, et al.International Immunopharmacology|February 13, 2024
Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinomaMeiying Song, Luoyang Wang, Suli Jiang, et al.International Immunopharmacology|August 14, 2023
IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatmentMeiying Song, Jie Liang, Luoyang Wang, et al.Cell Reports|October 21, 2020
PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell DysfunctionXiaozhe Yin, Wenfeng Zeng, Bowen Wu, et al.Molecular Immunology|August 30, 2025
CCL5: An emerging key target and progress in the targeted therapy of hepatocellular carcinomaXiaoli Liu, Jie Liang, Lizhen Zhao, et al.Nature Communications|July 2, 2026
TMEM216 inhibits breast cancer lung metastasis by modulating IGF1R-IRS4 signaling pathwayYingying Wang, Xinyang Bai, Zhiyuan Du, et al.Pageof 5